Picture of Rayence Co logo

228850 Rayence Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Annual cashflow statement for Rayence Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line13,827-4,07714,09321,84919,462
Depreciation
Amortisation
Non-Cash Items12,48712,21915,0956,4063,007
Unusual Items
Other Non-Cash Items
Changes in Working Capital-24,5207,069-14,922-16,602-773
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities9,45323,25420,93916,60725,820
Capital Expenditures-16,386-7,984-2,188-1,920-4,341
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-2,1773,420-18,0923,102-16,591
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-18,564-4,564-20,2801,182-20,933
Financing Cash Flow Items10,0001,2390
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities10,692-3,879-2,389-3,624-3,691
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,49514,979-2,25413,030923